Organogenesis (ORGO) Financials: Revenue & Earnings

ORGO price $0.85 -0.05 -5.97%

Ticker
ORGO
Price
$0.85
Change
-0.05 -5.97%
Market cap ?
$109.18M
Beta ?
1.27
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Fair value

ORGO fair value $4.86. Price $0.85. Price is 83% below fair value.

Above fair value, but less expensive than usual. A smaller premium than on more than 99% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare ORGO

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.17—52.10M
2026-08-06-0.71-0.3543.76M54.27M
2026-05-07-0.37-0.2936.25M43.26M
2026-02-260.310.21225.07M172.65M
2025-11-060.180.21150.86M172.68M
2025-08-07-0.090.07101.00M134.10M
2025-05-08-0.130.0486.69M90.77M
2025-02-270.04-0.03126.66M109.60M
2024-11-120.090.01115.18M106.93M
2024-08-08-0.13-0.02130.23M121.85M
2024-05-09-0.02-0.02109.98M101.05M
2024-02-29-0.00-0.0099.65M109.05M
2023-11-090.020.01108.53M111.43M
2023-08-090.040.03117.32M115.10M
2023-05-10-0.02-0.02107.64M95.52M
2023-03-010.060.05115.52M122.40M
2022-11-090.040.06116.86M120.85M
2022-08-090.070.08121.40M120.91M
2022-05-100.010.0598.12M95.95M
2022-03-010.390.08128.56M124.71M
2021-11-090.100.06113.75M112.67M
2021-08-090.150.07123.20M98.01M
2021-05-100.070.01102.55M507.63M
2021-03-160.150.14106.81M—
2020-11-090.19-0.08100.80M—
2020-08-10-0.05-0.1268.96M303.42M
2020-05-11-0.16-0.1261.73M50.16M
2020-03-09-0.04-0.1074.64M167.95M
2019-11-12-0.12-0.1364.27M69.62M
2019-08-09-0.11-0.1364.95M70.85M
2019-05-10-0.15-0.1057.12M36.96M
2019-03-18-0.12—63.60M—
2018-11-090.07———
2018-08-070.01———
2018-05-10-0.00———
2018-03-14-0.05—6.59M—
2017-11-14-0.23———
2017-08-110.04———
2017-05-120.02———
2017-03-28-0.02—61.08K—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-03-09Leibowitz Arthur SBuy5.00K$2.6813.40K
2026-03-09Driscoll Michael JosephBuy10.00K$2.6726.69K
2026-03-01Cavorsi RobertSell700$3.212.25K
2026-02-18Montecalvo Antonio S.Buy11.33K——
2026-02-18Montecalvo Antonio S.Sell3.78K$3.8414.51K
2026-02-18Gillheeney Gary S.Buy188.86K——
2026-02-18Gillheeney Gary S.Sell91.31K$3.84350.63K
2026-02-18Grow BrianBuy48.82K——
2026-02-18Grow BrianSell11.89K$3.8445.65K
2026-02-18Bilbo PatrickBuy49.10K——
2026-02-18Bilbo PatrickSell16.38K$3.8462.88K
2026-02-18Francisco DavidBuy44.04K——
2026-02-18Francisco DavidSell14.69K$3.8456.40K
2026-02-18Cavorsi RobertBuy16.45K——
2026-02-18Cavorsi RobertSell5.49K$3.8421.07K
2026-02-18Freedman LoriBuy43.21K——
2026-02-18Freedman LoriSell14.41K$3.8455.34K
2026-02-18McGuire PatrickOther0——
2026-02-18McGuire PatrickOther0——
2026-02-18McGuire PatrickOther0——
2026-02-18Freedman LoriBuy42.78K——
2026-02-18Freedman LoriSell14.27K$3.8454.79K
2026-02-18Freedman LoriBuy203.12K——
2026-02-18Freedman LoriBuy115.81K$3.84444.72K
2026-02-18Cavorsi RobertBuy16.29K——
2026-02-18Cavorsi RobertSell5.43K$3.8420.86K
2026-02-18Cavorsi RobertBuy93.75K——
2026-02-18Cavorsi RobertBuy53.45K$3.84205.26K
2026-02-18Francisco DavidBuy43.60K——
2026-02-18Francisco DavidSell14.54K$3.8455.84K
2026-02-18Francisco DavidBuy195.31K——
2026-02-18Francisco DavidBuy111.36K$3.84427.61K
2026-02-18Grow BrianBuy48.33K——
2026-02-18Grow BrianSell11.77K$3.8445.19K
2026-02-18Grow BrianBuy234.38K——
2026-02-18Grow BrianBuy133.63K$3.84513.14K
2026-02-18Bilbo PatrickBuy48.61K——
2026-02-18Bilbo PatrickSell16.21K$3.8462.25K
2026-02-18Bilbo PatrickBuy210.94K——
2026-02-18Bilbo PatrickBuy120.27K$3.84461.83K
2026-02-18Gillheeney Gary S.Buy186.97K——
2026-02-18Gillheeney Gary S.Sell90.40K$3.84347.13K
2026-02-18Gillheeney Gary S.Buy890.62K——
2026-02-18Gillheeney Gary S.Buy507.80K$3.841.95M
2026-02-18Driscoll Michael JosephBuy48.83K——
2026-02-18Giacomin Jon LBuy48.83K——
2026-02-18Leibowitz Arthur SBuy48.83K——
2026-02-18Montecalvo Antonio S.Buy11.22K——
2026-02-18Montecalvo Antonio S.Sell3.74K$3.8414.37K
2026-02-18Montecalvo Antonio S.Buy40.62K——
2026-02-18Montecalvo Antonio S.Buy23.16K$3.8488.94K
2026-02-18Quintero GilbertoBuy48.83K——
2026-02-18Duraibabu PrathyushaBuy48.83K——
2026-02-18Lustig GarrettBuy48.83K——
2026-02-18Korfin Michele IleneBuy48.83K——
2026-02-15Francisco DavidSell3.90K$3.7314.54K
2026-02-15Francisco DavidSell21.41K$3.7379.87K
2026-02-15Francisco DavidSell13.37K$3.7349.87K
2026-02-15Francisco DavidSell13.77K$3.7351.36K
2026-02-15Bilbo PatrickSell5.11K$3.7319.08K
2026-02-15Bilbo PatrickSell28.33K$3.73105.67K
2026-02-15Bilbo PatrickSell15.62K$3.7358.25K
2026-02-15Bilbo PatrickSell15.35K$3.7357.26K
2026-02-15Cavorsi RobertSell6.67K$3.7324.87K
2026-02-15Cavorsi RobertSell5.55K$3.7320.70K
2026-02-15Cavorsi RobertSell5.44K$3.7320.30K
2026-02-15Freedman LoriSell4.04K$3.7315.08K
2026-02-15Freedman LoriSell24.43K$3.7391.12K
2026-02-15Freedman LoriSell12.76K$3.7347.60K
2026-02-15Freedman LoriSell13.51K$3.7350.39K
2026-02-15Gillheeney Gary S.Sell24.34K$3.7390.79K
2026-02-15Gillheeney Gary S.Sell78.65K$3.73293.35K
2026-02-15Gillheeney Gary S.Sell82.81K$3.73308.90K
2026-02-15Gillheeney Gary S.Sell85.61K$3.73319.31K
2026-02-15Grow BrianSell3.35K$3.7312.48K
2026-02-15Grow BrianSell18.91K$3.7370.53K
2026-02-15Grow BrianSell10.56K$3.7339.39K
2026-02-15Grow BrianSell11.14K$3.7341.57K
2026-02-15Montecalvo Antonio S.Sell1.39K$3.735.18K
2026-02-15Montecalvo Antonio S.Sell9.61K$3.7335.83K
2026-02-15Montecalvo Antonio S.Sell4.10K$3.7315.29K
2026-02-15Montecalvo Antonio S.Sell3.52K$3.7313.14K
2025-12-16NUSSDORF GLENN HSell200.00K$5.141.03M
2025-11-26NUSSDORF GLENN HSell187.96K$5.29994.29K
2025-11-25NUSSDORF GLENN HSell12.04K$5.3063.83K
2025-11-24NUSSDORF GLENN HSell100.00K$5.34534.00K
2025-08-11Grow BrianBuy4.06K$2.4710.03K
2025-08-11Grow BrianSell2.17K$4.6210.03K
2025-08-11Grow BrianSell4.06K$2.4710.03K
2025-07-16Cavorsi RobertSell360$4.461.61K
2025-06-10NUSSDORF GLENN HSell18.62K$3.5666.26K
2025-06-09NUSSDORF GLENN HSell4.16K$3.5014.55K
2025-06-06Freedman LoriBuy9.02K$2.9926.95K
2025-06-05Freedman LoriBuy142.38K$2.91413.63K
2025-06-04Freedman LoriBuy100.86K$2.82284.72K
2025-05-15NUSSDORF GLENN HBuy107.49K$2.99321.00K
2025-05-14NUSSDORF GLENN HBuy251.00K$3.09775.04K
2025-03-09Cavorsi RobertSell210$5.161.08K
2025-03-09Cavorsi RobertSell61$5.16315
2025-03-04Driscoll Michael JosephSell25.00K$5.10127.53K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 137, holders +16 vs prior quarter. Ownership 52.03%.

HolderSharesChangeChange %Value
MORGAN STANLEY11.72M104.81K+0.90%28.48M
SOLEUS CAPITAL MANAGEMENT, L.P.10.14M55.00K+0.55%24.64M
BLACKROCK, INC.7.25M2.35M+47.96%17.62M
DIMENSIONAL FUND ADVISORS LP3.05M159.29K+5.51%7.41M
AQR CAPITAL MANAGEMENT LLC3.01M2.13M+241.58%7.32M
VANGUARD CAPITAL MANAGEMENT LLC2.91M5.10K+0.18%7.06M
D. E. SHAW & CO., INC.2.89M590.34K+25.69%7.02M
ASSENAGON ASSET MANAGEMENT S.A.1.97M00.00%4.78M
GEODE CAPITAL MANAGEMENT, LLC1.94M151.59K+8.50%4.70M
DEUTSCHE BANK AG\1.71M505+0.03%4.15M
VANGUARD PORTFOLIO MANAGEMENT LLC1.61M158.64K+10.95%3.91M
ACADIAN ASSET MANAGEMENT LLC1.55M-31.56K-2.00%3.75M
STATE STREET CORP1.52M-5.15K-0.34%3.69M
RENAISSANCE TECHNOLOGIES LLC1.02M-51.42K-4.81%2.47M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC905.02K25.19K+2.86%2.20M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.905.02K905.02KNew2.20M
GOLDMAN SACHS GROUP INC887.40K367.05K+70.54%2.16M
CITADEL ADVISORS LLC867.93K323.69K+59.48%2.11M
SG AMERICAS SECURITIES, LLC772.74K-18.03K-2.28%1.88M
JACOBS LEVY EQUITY MANAGEMENT, INC692.20K692.20KNew1.68M
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND628.70K628.70KNew1.53M
NORTHERN TRUST CORP584.58K30.15K+5.44%1.42M
BANK OF AMERICA CORP /DE/563.05K14.79K+2.70%1.37M
SPHERA FUNDS MANAGEMENT LTD.550.00K00.00%1.34M
NORGES BANK530.90K530.90KNew1.29M

Earnings and financials

Organogenesis Holdings Inc. (ORGO) trades at $0.85, with a market cap of $109.18M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Organogenesis (ORGO) Financials: Revenue & Earnings

ORGO$0.85-0.05 -5.97%

$109.18M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History